{"id":871371,"date":"2025-09-08T00:13:46","date_gmt":"2025-09-08T05:13:46","guid":{"rendered":"https:\/\/newsycanuse.com\/index.php\/2025\/09\/08\/aurobindo-pharma-exclusive-cfo-says-zentiva-fits-into-strategic-plans-but-talks-in-early-stage\/"},"modified":"2025-09-08T00:13:46","modified_gmt":"2025-09-08T05:13:46","slug":"aurobindo-pharma-exclusive-cfo-says-zentiva-fits-into-strategic-plans-but-talks-in-early-stage","status":"publish","type":"post","link":"https:\/\/newsycanuse.com\/index.php\/2025\/09\/08\/aurobindo-pharma-exclusive-cfo-says-zentiva-fits-into-strategic-plans-but-talks-in-early-stage\/","title":{"rendered":"Aurobindo Pharma Exclusive: CFO says Zentiva fits into strategic plans, but talks in ‘early stage’"},"content":{"rendered":"
\n

Home<\/a><\/span>Market News<\/a><\/span>Aurobindo Pharma Exclusive: CFO says Zentiva fits into strategic plans, but talks in ‘early stage’<\/span><\/p>\n

\n
\n

Aurobindo Pharma CFO Santhanam Subramanian said that while Zentiva fits into Aurobindo Pharma’s strategic plans as it is based out of Europe, it is too premature to comment on a possible outcome due to the early stages of the discussion.<\/h2>\n<\/p>\n
\n

\"Aurobindo<\/p>\n

\n
\n

Aurobindo Pharma Ltd. has entered into a Non Disclosure and Confidentiality agreement for its potential acquisition of Zentiva and talks are currently at a “very early stage,” CFO Santhanam Subramanian confirmed exclusively to CNBC-TV18 on Thursday, August 21.<\/p>\n

\nSubramanian said that while Zentiva fits into Aurobindo Pharma’s strategic plans as it is based out of Europe, it is too premature to comment on a possible outcome due to the early stages of the discussion. The Aurobindo CFO did highlight that in case a deal fructifies, the announcement can be made in the next two months.<\/p>\n

\nAurobindo Pharma’s shares fell 4% on Wednesday after reports indicated that the company is set to acquire Zentiva at a price between $5 billion to $5.5 billion. In response to that ET report, Aurobindo replied to the exchanges that they keep pursuing growth opportunities and will make appropriate announcements as and when such a situation arises.<\/p>\n

\nAurobindo Pharma currently has $140 million worth of cash on the books and 75% of its business comes from the US and European markets.<\/p>\n

\nSubramanian said that while there is nothing wrong in looking at a large entity for an acquisition, they will be mindful of not overpaying for any deal. He added that Aurobindo will look at paying a single-digit multiple for any deal that they do.<\/p>\n

\nThe CFO also addressed concerns around a potential rise in debt in case the acquisition does materialise. He mentioned that debt is not a concern for them as the continue to generate healthy cash flow every quarter.<\/p>\n

This is a developing story and will be updated with more.<\/em><\/p>\n<\/div>\n

\n

First Published:\u00a0<\/p>\n

Aug 21, 2025 9:08 AM<\/p>\n

IST<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n

Hormaz Fatakia
Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Home Market News Aurobindo Pharma Exclusive: CFO says Zentiva fits into strategic plans, but talks in ‘early stage’ Aurobindo Pharma CFO Santhanam Subramanian said that while Zentiva fits into Aurobindo Pharma’s strategic plans as it is based out of Europe, it is too premature to comment on a possible outcome due to the early stages<\/p>\n","protected":false},"author":1,"featured_media":871372,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[146173,562],"tags":[146172,9871],"class_list":{"0":"post-871371","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-aurobindo","8":"category-pharma","9":"tag-aurobindo","10":"tag-pharma"},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts\/871371","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/comments?post=871371"}],"version-history":[{"count":0,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts\/871371\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/media\/871372"}],"wp:attachment":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/media?parent=871371"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/categories?post=871371"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/tags?post=871371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}